Integrated molecular analysis of adult T cell leukemia/lymphoma

Keisuke Kataoka, Yasunobu Nagata, Akira Kitanaka, +56

Nature Genetics

Lymphoid NeoplasiaMedicineMixed-phenotype Acute LeukemiaMolecular AnalysisImmunology +5

Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers

Keisuke Kataoka, Yuichi Shiraishi, Yohei Takeda, +41

Nature

Aberrant Pd-l1 ExpressionCancer Cell BiologyPathologyMolecular OncologyCancer Genetics +3

Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma

Keisuke Kataoka, Masako Iwanaga, Jun‐ichirou Yasunaga, +40

Blood

Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice

Yoshinori Ozono, Kotaro Shide, Takuro Kameda, +14

Leukemia

Whole-genome landscape of adult T-cell leukemia/lymphoma

Yasunori Kogure, Takuro Kameda, Junji Koya, +43

Blood

TET2 is essential for survival and hematopoietic stem cell homeostasis

Kotaro Shide, Takuro Kameda, Haruko Shimoda, +17

Leukemia

Cell TherapyMedicineStem Cell MobilizationT-regulatory CellImmunology +6

Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator

Takuro Kameda, Kotaro Shide, Takumi Yamaji, +22

Blood

Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma

Tomonori Hidaka, Shingo Nakahata, Kinta Hatakeyama, +14

Blood

Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib

Kotaro Shide, Takuro Kameda, Takumi Yamaji, +20

Leukemia

Clinical significance of CADM1/TSLC1/IgSF4 expression in adult T-cell leukemia/lymphoma

Shingo Nakahata, Yusuke Saito, Kousuke Marutsuka, +14

Leukemia

Adult T-cell Leukemia/lymphomaImmunologyPathologyAdult T-cell Leukemia-lymphomaMedicine +1